Business ethics, medical ethics and economic medicalization

Geoffrey Poitras

International Journal of Business Governance and Ethics, 2009, vol. 4, issue 4, 372-389

Abstract: This paper explores the ethical implications of economic medicalization: where non-medical problems are transformed into medical problems in order to achieve the objective of shareholder wealth maximization. After considering differences between business ethics and medical ethics, economic medicalization arising from corporate marketing strategies is detailed. Both direct-to-consumer and more traditional physician centred marketing methods are considered. In addition, the economic medicalization of medical research practice and publication is examined and future trends are identified.

Keywords: economic medicalization; direct-to-consumer marketing; muzzle clause; shareholder wealth maximization; SWM; medical ethics; business ethics; corporate marketing; marketing strategies; medical research. (search for similar items in EconPapers)
Date: 2009
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.inderscience.com/link.php?id=23789 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijbget:v:4:y:2009:i:4:p:372-389

Access Statistics for this article

More articles in International Journal of Business Governance and Ethics from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().